Research Funding

Ongoing

  • Research program Development and Study of Drugs (Progres Q42)

Past

The Education for Competitiveness Operational Program (ECOP), European Union-Funded Projects:

  • CZ.1.07/2.3.00/30.0061 - Increasing of the R&D capacity at Charles University through new positions for graduates of doctoral studies (2012 – 2015)
  • CZ.1.07/2.3.00/30.0022 - Supporting of establishment, development and mobility of quality research teams at the Charles University (2012 – 2014)

Czech Science Foundation (GA ČR):

  • GAP304/10/1738 Radiolabelled neuropeptides for cancer diagnosis and treatment (2010-2012)
  • GA305/07/0535 Receptor-specific radiopharmaceuticals for imaging and therapy of cancers (2007-2009)

Grant Agency, Ministry of Health of Czech Republic (IGA MZ ČR):

  • NT12398 Study on relationships between toxicity and transport mechanism of antivirals (2011-2014)
  • NT13346 Design and enzyme targeting of antibacterial active compounds against multidrug resistant strains (2012-2015)
  • NR9208 Possibility of modification of nephrotoxicity of radiopharmaceuticals from the group of somatostatin analogs (2007-2009)
  • NR9206 Study on mechanisms of selected drug-drug interactions in onkology (2007-2009)
  • NS10367 Evaluation and development of new perspective antimycobacterial drugs and prodrugs active against multidrug resistant strains (2009-2011)

Ministry of Education, Youth and Sports (MŠMT):

  • OC08006 Targeted cancer radiotherapy in preclinical experiment (2008-2011)
  • OE08018 Radionuclide precursors and radiopharmaceuticals for targeted radionuclide imaging and therapy (2008-2011)
  • OC B12.001 Study of pharmacokinetics and biodistribution of radiolabelled biologically active peptides in laboratory animals (2001-2004)

Ministry of Industry and Trade (MPO):

  • FT-TA2/081 Targeted supercancerostatics of new generation for leucemia therapy (2005-2008)

Grant Agency of Charles University (GA UK):

  • 998216 Radiolabeled ramucirumab for targeted radiotherapy and molecular imaging and its in vitro biological evaluation (2016-2019)
  • 30216 Interactions of the intestinal OATP transporters with flavonoids and their potential importance for drug transport (2016-2017)
  • 360811 Studium mechanismů ledvinného membránového transportu antivirotik in vitro s využitím buněčných modelů (2011-2013)
  • 376411 Studium transportu receptorově specifických peptidů v ledvinách in vitro (2011-2013)
  • 124409 Mechanismy membránového transportu radionuklidy značených derivátů somatostatinu a dimerkaptosukcinátu (2009-2011)

© Univerzita Karlova, Farmaceutická fakulta v Hradci Králové, Akademika Heyrovského 1203, 500 03 Hradec Králové, Česká republika
O webu a cookies | Powered by Kentico